Science Explorer Back to mapMap
Discussion

Gestational Diabetes Research and Management

Gestational Diabetes Research and Management is a research topic within Obstetrics and Gynecology. Science Explorer counts 36k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers explores the impact of gestational diabetes mellitus (GDM) and related factors such as maternal obesity, hyperglycemia, and metabolic syndrome on pregnancy outcomes, fetal development, and long-term health implications for both mothers and offspring. It covers topics such as diagnosis, classification, treatment, prevention, and long-term consequences of GDM, as well as the association with type 2 diabetes and cardiovascular disease. Additionally, it investigates the influence of maternal weight gain, macrosomia, and metabolic imprinting on offspring health.

  • Gestational Diabetes Mellitus
  • Maternal Obesity
  • Pregnancy Outcomes
  • Type 2 Diabetes
  • Metabolic Syndrome
  • Maternal Weight Gain
  • Fetal Development
  • Adverse Pregnancy Outcomes
  • Hyperglycemia
  • Offspring Health
Research works
36k
fractional, since 1950
In the world top 10%
3.5k
per year above
Top-10% rate
10.0%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+10%
the tick is no change
Largest producer
United States
31% of the 10 largest, 2022-now
Gestational Diabetes Research and Management

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Gestational Diabetes Research and Management research?

By volume, the United States and China publish the most (1.8k and 1.4k works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.8k works
  2. 2 China 1.4k works
  3. 3 India 574 works
  4. 4 United Kingdom 434 works
  5. 5 Australia 336 works
  6. 6 Canada 320 works
  7. 7 Brazil 319 works
  8. 8 Türkiye 272 works
  9. 9 Indonesia 197 works
  10. 10 Iran 188 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 31.1%China: 24.1%India: 9.7%United Kingdom: 7.4%6 others listed: 27.7%31%largest
United States1,833 · 31.1%China1,424 · 24.1%India574 · 9.7%United Kingdom434 · 7.4%6 others listed1,631 · 27.7%

Shares of the rows listed above, not of the whole node.

Which institutions lead Gestational Diabetes Research and Management research?

By volume in 2022-now, Harvard University publishes the most Gestational Diabetes Research and Management research, followed by University of Toronto and Shanghai Jiao Tong University.

Who are the leading researchers in Gestational Diabetes Research and Management?

The most-cited researchers publishing on Gestational Diabetes Research and Management include Douglas G. Altman, George Davey Smith and Ali H. Mokdad.

  1. 1 Douglas G. Altman United Kingdom 862k citations
  2. 2 George Davey Smith United Kingdom 435k citations
  3. 3 Ali H. Mokdad United States 429k citations
  4. 4 Walter Churchill Willett United States 411k citations
  5. 5 Mark J. Daly United States 403k citations
  6. 6 Zulfiqar Ahmed Bhutta Pakistan 371k citations
  7. 7 Hermann Brenner Germany 343k citations
  8. 8 Cyrus Cooper United Kingdom 342k citations
  9. 9 Jun Wang China 340k citations
  10. 10 Mika Kivimäki United Kingdom 318k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Gestational Diabetes Research and Management?

The most cited paper in Gestational Diabetes Research and Management is "World Health Organization 2020 guidelines on physical activity and sedentary behaviour" (Fiona Bull et al., 2020), with 11,799 citations. Next come "IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045" (7,503) and "Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records" (4,059).

Most cited papers
#PaperReleasedCitations
1 World Health Organization 2020 guidelines on physical activity and sedentary behaviour Fiona Bull et al. · British Journal of Sports Medicine Open access 25 Nov 2020 11,799
2 IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045 N.H. Cho, Jonathan Edward Shaw, Suvi Karuranga et al. · Diabetes Research and Clinical Practice 26 Feb 2018 7,503
3 Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records Huijun Chen, Juanjuan Guo, Chen Wang et al. · The Lancet Open access 12 Feb 2020 4,059
4 Fetal origins of coronary heart disease D.J.P. Barker · BMJ Open access 15 Jul 1995 3,568
5 Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis Leanne Bellamy, Juan-Pablo Casas, Aroon Dinesh Hingorani et al. · The Lancet Review May 2009 3,325
All 100 most cited papers, with filters and sorting

Where is Gestational Diabetes Research and Management research done?

The largest centres of Gestational Diabetes Research and Management research in 2022-now are Beijing (China), London (United Kingdom), Shanghai (China) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Aurora, Oakland and Portland.

Largest cities, 2022-now

  1. 1 BeijingChina 180 works
  2. 2 LondonUnited Kingdom 132 works
  3. 3 ShanghaiChina 113 works
  4. 4 GuangzhouChina 97 works
  5. 5 MelbourneAustralia 83 works
  6. 6 HangzhouChina 79 works
  7. 7 IstanbulTürkiye 72 works
  8. 8 TorontoCanada 71 works
  9. 9 New YorkUnited States 71 works
  10. 10 BostonUnited States 70 works

Where it is the local speciality

  1. AuroraUS · 26.6 works7.2×
  2. OaklandUS · 22.1 works6.1×
  3. PortlandUS · 32.5 works5.4×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Gestational Diabetes Research and Management than the world average.

See Gestational Diabetes Research and Management on the map

Where is the best place to study Gestational Diabetes Research and Management?

Among universities, judged by research, Harvard University, Karolinska Institutet and University of Cambridge score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 17.19%fractional works in this field (log) →share of work in the world top 10% →University of Cambri…Karolinska InstitutetHarvard UniversityShanghai Jiao Tong U…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 70.117.2%2.9×74 -12.0%
2Karolinska InstitutetSweden 67.719.0%6.4×29 +8.5%
3University of CambridgeUnited Kingdom 65.325.2%2.4×23 -28.6%
4Shanghai Jiao Tong UniversityChina 63.015.8%2.3×53 +24.8%
5University of GondarEthiopia 63.026.4%8.3×10 +83.0%
6Zhejiang UniversityChina 60.614.4%2.2×47 +155.2%
7Nanjing Medical UniversityChina 59.515.4%5.2×37 +45.5%
8Peking UniversityChina 59.313.8%2.9×48 +21.1%
9University of TorontoCanada 58.714.1%3.3×53 -18.7%
10University of CopenhagenDenmark 58.510.6%3.8×29 +24.4%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Gestational Diabetes Research and Management, country by country

Is Gestational Diabetes Research and Management research growing?

Output in 2022-2025 was 10% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Gestational Diabetes Research and Management.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Gestational Diabetes Research and Management as a percentage of every work published that year, 0.035% in 2024.

still counting0.020%0.040%0.060%Gestational Diabetes Research and Management0.038% in 202519801990200020102020

Fractional works of Gestational Diabetes Research and Management over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Gestational Diabetes Research and Management10.2% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Gestational Diabetes Research and Management. Posts are plain text and can be reported.